An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Cerebral palsy in under 25s: assessment and management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2017 Jan. (NICE Guideline, No. 62.)
Top results in this bookTable of Contents
Parkinson’s disease in adults: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2017 Jul. (NICE Guideline, No. 71.)
Addendum to Psychosis and schizophrenia in children and young people.
London: National Institute for Health and Care Excellence (NICE); 2016 May. (Clinical Guideline Addendum, No. 155.1.)
Foslevodopa-Foscarbidopa (Vyalev): CADTH Reimbursement Recommendation: Indication: For the treatment of motor fluctuations in patients with advanced levodopa-responsive Parkinson’s disease who do not have satisfactory control of severe, debilitating motor fluctuations and hyper-/dyskinesia despite optimized treatment with available combinations of Parkinson’s medicinal products [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jul.
CADTH Canadian Drug Expert Committee Recommendation: AbobotulinumtoxinA (Dysport Therapeutic — Ipsen Biopharmaceuticals Canada, Inc.): Indication: To reduce the subjective symptoms and objective signs of cervical dystonia (spasmodic torticollis) in adults [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Jul.
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda.
Washington (DC): National Academies Press (US); 2017 Jan 12.
Suspected neurological conditions: recognition and referral.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 127.)
Mental Health Problems in People with Learning Disabilities: Prevention, Assessment and Management.
London: National Institute for Health and Care Excellence (NICE); 2016 Sep. (NICE Guideline, No. 54.)
CADTH Canadian Drug Expert Committee Recommendation: Levodopa/Carbidopa Intestinal Gel (Duodopa — Abbvie Corporation): Indication: Parkinson’s disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.
Psychosis and schizophrenia in adults: prevention and management.
London: National Institute for Health and Care Excellence (NICE); 2014 Mar. (NICE Clinical Guidelines, No. 178.)
Psychosis and schizophrenia in children and young people: recognition and management.
London: National Institute for Health and Care Excellence (NICE); 2016 Oct. (NICE Clinical Guidelines, No. 155.)
Pharmacological Treatment of Mental Disorders in Primary Health Care.
Geneva: World Health Organization; 2009.
Cerebral palsy in adults.
London: National Institute for Health and Care Excellence (NICE); 2019 Jan 15. (NICE Guideline, No. 119.)
Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach [Internet].
Geneva: World Health Organization; 2021 Jul.
Spasticity in under 19s: management.
London: National Institute for Health and Care Excellence (NICE); 2016 Nov. (NICE Clinical Guidelines, No. 145.)
Psychosis with Coexisting Substance Misuse: Assessment and Management in Adults and Young People.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society (UK); 2011. (NICE Clinical Guidelines, No. 120.)
Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders [Internet].
Geneva: World Health Organization; 2023.
Cariprazine (Vraylar): CADTH Reimbursement Recommendation: Indication: For the treatment of schizophrenia in adults [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Feb.
Cariprazine (Vraylar): CADTH Reimbursement Recommendation: Indication: As monotherapy for: bipolar mania: acute management of manic or mixed episodes associated with bipolar I disorder in adults, and bipolar depression: acute management of depressive episodes associated with bipolar I disorder in adults [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov.
Antisocial behaviour and conduct disorders in children and young people: recognition and management.
London: National Institute for Health and Care Excellence (NICE); 2017 Apr. (NICE Clinical Guidelines, No. 158.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on